{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T12:51:00Z","timestamp":1793451060559,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.intimp.2024.112360","type":"journal-article","created":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T04:43:40Z","timestamp":1717821820000},"page":"112360","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Anti-TL1A monoclonal antibody modulates the dysregulation of Th1\/Th17 cells and attenuates granuloma formation in sarcoidosis by inhibiting the PI3K\/AKT signaling pathway"],"prefix":"10.1016","volume":"137","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6243-5438","authenticated-orcid":false,"given":"Chengxing","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqi","family":"Na","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajia","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaifang","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanting","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9700-4504","authenticated-orcid":false,"given":"Jingjing","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.intimp.2024.112360_b0005","doi-asserted-by":"crossref","first-page":"766","DOI":"10.3390\/cells10040766","article-title":"Sarcoidosis: a clinical overview from symptoms to diagnosis","volume":"10","author":"S\u00e8ve","year":"2021","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.intimp.2024.112360_b0010","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/joim.13629","article-title":"Sarcoidosis: epidemiology and clinical insights","volume":"293","author":"Rossides","year":"2023","journal-title":"J. Intern. Med."},{"issue":"1","key":"10.1016\/j.intimp.2024.112360_b0015","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3390\/cells11010059","article-title":"Clinical features, histopathology and differential diagnosis of sarcoidosis","volume":"11","author":"Tana","year":"2021","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.intimp.2024.112360_b0020","doi-asserted-by":"crossref","first-page":"233","DOI":"10.5858\/arpa.2020-0543-RA","article-title":"Pathology of granulomatous pulmonary diseases","volume":"146","author":"Rosen","year":"2022","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"11","key":"10.1016\/j.intimp.2024.112360_b0025","doi-asserted-by":"crossref","first-page":"474","DOI":"10.3389\/fimmu.2020.00474","article-title":"Adaptive immunity in pulmonary sarcoidosis and chronic beryllium disease","volume":"18","author":"Greaves","year":"2020","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2024.112360_b0030","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12931-022-01971-5","article-title":"Infliximab therapy in refractory sarcoidosis: a multicenter real-world analysis","volume":"23","author":"Sakkat","year":"2022","journal-title":"Respir. Res."},{"issue":"1","key":"10.1016\/j.intimp.2024.112360_b0035","first-page":"187","article-title":"The promise of JAK inhibitors for treatment of sarcoidosis and other inflammatory disorders with macrophage activation: a review of the literature","volume":"93","author":"Wang","year":"2020","journal-title":"Yale. J. Biol. Med."},{"issue":"1","key":"10.1016\/j.intimp.2024.112360_b0040","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12948-015-0022-z","article-title":"TL1A\/DR3 axis involvement in the inflammatory cytokine network during pulmonary sarcoidosis","volume":"13","author":"Facco","year":"2015","journal-title":"Clin. Mol. Allergy."},{"key":"10.1016\/j.intimp.2024.112360_b0045","article-title":"Role of TL1A in inflammatory autoimmune diseases: a comprehensive review","volume":"13","author":"Xu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.112360_b0050","article-title":"TL1A\/DR3 axis, a key target of TNF-a, augments the epithelial-mesenchymal transformation of epithelial cells in OVA-induced asthma","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2024.112360_b0055","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S1074-7613(02)00283-2","article-title":"TL1A is a TNF-like ligand for DR3 and TR6\/DcR3 and functions as a T cell costimulator","volume":"16","author":"Migone","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2024.112360_b0060","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3389\/fimmu.2019.00583","article-title":"TL1A (TNFSF15) and DR3 (TNFRSF25): a Co-stimulatory system of cytokines with diverse functions in gut mucosal immunity","volume":"10","author":"Valatas","year":"2019","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2024.112360_b0065","doi-asserted-by":"crossref","first-page":"693","DOI":"10.3892\/etm.2021.10125","article-title":"Analysis of therapeutic potential of preclinical models based on DR3\/TL1A pathway modulation (Review)","volume":"22","author":"Yu","year":"2021","journal-title":"Exp. Ther. Med."},{"issue":"34","key":"10.1016\/j.intimp.2024.112360_b0070","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2120771120","article-title":"Tumor necrosis factor-like cytokine 1A plays a role in inflammatory bowel disease pathogenesis","volume":"120","author":"Meng","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.intimp.2024.112360_b0075","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/mi.2010.70","article-title":"Sustained TL1A expression modulates effector and regulatory T-cell responses and drives intestinal goblet cell hyperplasia","volume":"4","author":"Taraban","year":"2011","journal-title":"Mucosal. Immunol."},{"issue":"11","key":"10.1016\/j.intimp.2024.112360_b0080","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1016\/j.cgh.2021.06.011","article-title":"Anti-TL1A antibody PF-06480605 safety and efficacy for ulcerative colitis: a phase 2a Single-arm study","volume":"19","author":"Danese","year":"2021","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"7","key":"10.1016\/j.intimp.2024.112360_b0085","doi-asserted-by":"crossref","first-page":"760","DOI":"10.2174\/1389450122999210120205607","article-title":"TL1A: a new potential target in the treatment of inflammatory bowel disease","volume":"22","author":"Furfaro","year":"2021","journal-title":"Curr. Drug. Targets"},{"issue":"3","key":"10.1016\/j.intimp.2024.112360_b0090","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/ibd\/izab193","article-title":"Antitumor necrosis factor-like ligand 1A therapy targets tissue inflammation and fibrosis pathways and reduces gut pathobionts in ulcerative colitis","volume":"28","author":"Hassan-Zahraee","year":"2022","journal-title":"Inflamm. Bowel. Dis."},{"issue":"2","key":"10.1016\/j.intimp.2024.112360_b0095","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1164\/ajrccm.160.2.ats4-99","volume":"160","author":"Costabel","year":"1999","journal-title":"Am J Respir Crit Care Med."},{"issue":"2","key":"10.1016\/j.intimp.2024.112360_b0100","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1165\/rcmb.2009-0350OC","article-title":"Development of a sarcoidosis murine lung granuloma model using mycobacterium superoxide dismutase a peptide","volume":"44","author":"Swaisgood","year":"2011","journal-title":"Am. J. Respir. Cell. Mol. Biol."},{"issue":"9","key":"10.1016\/j.intimp.2024.112360_b0105","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1164\/rccm.202112-2771OC","article-title":"Pentraxin 3 inhibits complement-driven macrophage activation to restrain granuloma formation in sarcoidosis","volume":"206","author":"Gon\u00e7ales","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.intimp.2024.112360_b0110","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/sms.12702","article-title":"An overview of technical considerations for Western blotting applications to physiological research","volume":"27","author":"Bass","year":"2017","journal-title":"Scand. J. Med. Sci. Sports"},{"issue":"4","key":"10.1016\/j.intimp.2024.112360_b0115","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1440-1843.2007.01084.x","article-title":"Reference values of diffusing capacity of non-smoking Chinese in Hong Kong","volume":"12","author":"Ip","year":"2007","journal-title":"Respirology"},{"issue":"11","key":"10.1016\/j.intimp.2024.112360_b0120","doi-asserted-by":"crossref","first-page":"4538","DOI":"10.21037\/jtd.2017.10.110","article-title":"Reference values for spirometry in Chinese aged 4\u201380 years","volume":"9","author":"Jian","year":"2017","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.intimp.2024.112360_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2020.105936","article-title":"Randomised, placebo-controlled trial of dexamethasone for quality of life in pulmonary sarcoidosis","volume":"165","author":"Vis","year":"2020","journal-title":"Respir. Med."},{"issue":"11","key":"10.1016\/j.intimp.2024.112360_b0130","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMra2101555","article-title":"Challenges of sarcoidosis and its management","volume":"385","author":"Drent","year":"2021","journal-title":"N Engl. J. Med."},{"key":"10.1016\/j.intimp.2024.112360_b0135","article-title":"The role of diverse immune cells in sarcoidosis","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Immunol."},{"issue":"19","key":"10.1016\/j.intimp.2024.112360_b0140","doi-asserted-by":"crossref","first-page":"7398","DOI":"10.3390\/ijms21197398","article-title":"Key players and biomarkers of the adaptive immune system in the pathogenesis of sarcoidosis","volume":"21","author":"Zhou","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2024.112360_b0145","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s12931-023-02488-1","article-title":"Identification of a novel role for TL1A\/DR3 deficiency in acute respiratory distress syndrome that exacerbates alveolar epithelial disruption","volume":"24","author":"Zhang","year":"2023","journal-title":"Respir. Res."},{"issue":"9","key":"10.1016\/j.intimp.2024.112360_b0150","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.4049\/jimmunol.2000665","article-title":"TL1A promotes lung tissue fibrosis and airway remodeling","volume":"205","author":"Herro","year":"2020","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2024.112360_b0155","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1053\/j.gastro.2008.04.037","article-title":"TL1A (TNFSF15) regulates the development of chronic colitis by modulating both T-helper 1 and T-helper 17 activation","volume":"135","author":"Takedatsu","year":"2008","journal-title":"Gastroenterology"},{"issue":"40","key":"10.1016\/j.intimp.2024.112360_b0160","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2208436119","article-title":"Biosensors for inflammation as a strategy to engineer regulatory T cells for cell therapy","volume":"119","author":"Bittner","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.intimp.2024.112360_b0165","article-title":"Pulmonary fibrosis in sarcoidosis","volume":"40","author":"Asif","year":"2023","journal-title":"Sarcoidosis Vasc. Diffuse. Lung. Dis."},{"issue":"5","key":"10.1016\/j.intimp.2024.112360_b0170","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1183\/09031936.00089910","article-title":"T-helper cell type-1 transcription factor T-bet is upregulated in pulmonary sarcoidosis","volume":"38","author":"Kriegova","year":"2011","journal-title":"Eur. Respir. J."},{"issue":"5","key":"10.1016\/j.intimp.2024.112360_b0175","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s10787-015-0247-y","article-title":"T-bet and interleukin-27: possible TH1 immunomodulators of sarcoidosis","volume":"23","author":"Loke","year":"2015","journal-title":"Inflammopharmacology"},{"issue":"3","key":"10.1016\/j.intimp.2024.112360_b0180","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.toxlet.2004.10.011","article-title":"Antifibrotic effect of interferon gamma in silicosis model of rat","volume":"155","author":"Chen","year":"2005","journal-title":"Toxicol. Lett."},{"issue":"4","key":"10.1016\/j.intimp.2024.112360_b0185","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.alit.2018.02.011","article-title":"TARC expression in the circulation and cutaneous granulomas correlates with disease severity and indicates Th2-mediated progression in patients with sarcoidosis","volume":"67","author":"Nguyen","year":"2018","journal-title":"Allergol. Int."},{"issue":"2","key":"10.1016\/j.intimp.2024.112360_b0190","first-page":"98","article-title":"Type 2 macrophages and Th2 CD4+ cells in interstitial lung diseases (ILDs): an overview","volume":"35","author":"Partida-Zavala","year":"2018","journal-title":"Sarcoidosis Vasc. Diffuse. Lung. Dis."},{"issue":"13","key":"10.1016\/j.intimp.2024.112360_b0195","doi-asserted-by":"crossref","first-page":"10767","DOI":"10.3390\/ijms241310767","article-title":"Molecular mechanism in the development of pulmonary fibrosis in patients with sarcoidosis","volume":"24","author":"Cocconcelli","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.intimp.2024.112360_b0200","doi-asserted-by":"crossref","first-page":"5212","DOI":"10.4049\/jimmunol.1002374","article-title":"The adaptor protein TRADD is essential for TNF-like ligand 1A\/death receptor 3 signaling","volume":"186","author":"Pobezinskaya","year":"2011","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.intimp.2024.112360_b0205","doi-asserted-by":"crossref","first-page":"19911","DOI":"10.1002\/jcp.28589","article-title":"Phosphoinositide 3-kinase\/protein kinase B inhibition restores regulatory T cell's function in pulmonary sarcoidosis","volume":"234","author":"Zhang","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"5","key":"10.1016\/j.intimp.2024.112360_b0210","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3892\/etm.2023.11923","article-title":"Inhibition of phosphoinositide\u20133 kinases \u03b3\/\u03b4 ameliorates pulmonary granuloma by rescuing Treg function in a sarcoidosis model","volume":"25","author":"Zhang","year":"2023","journal-title":"Exp. Ther. Med."},{"issue":"1","key":"10.1016\/j.intimp.2024.112360_b0215","first-page":"50","article-title":"NF-kappaB activation in sarcoidosis","volume":"18","author":"Drent","year":"2001","journal-title":"Sarcoidosis Vasc. Diffuse. Lung. Dis."},{"issue":"4","key":"10.1016\/j.intimp.2024.112360_b0220","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1164\/rccm.200905-0696OC","article-title":"Serum amyloid A regulates granulomatous inflammation in sarcoidosis through Toll-like receptor-2","volume":"181","author":"Chen","year":"2010","journal-title":"Am. J. Respir. Crit. Care. Med."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924008804?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924008804?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T15:33:14Z","timestamp":1720279994000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924008804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":44,"alternative-id":["S1567576924008804"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112360","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-TL1A monoclonal antibody modulates the dysregulation of Th1\/Th17 cells and attenuates granuloma formation in sarcoidosis by inhibiting the PI3K\/AKT signaling pathway","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112360","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112360"}}